Reversible promoter demethylation of PDGFD confers gemcitabine resistance through STAT3 activation and RRM1 upregulation-Reference-Cited by-同舟云学术

Reversible promoter demethylation of PDGFD confers gemcitabine resistance through STAT3 activation and RRM1 upregulation

Published:2023-07 Issue: Volume:567 Page:216266
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Qin Li,Dong Zizheng,Huang Caoqinglong,Liu Hao,Beebe Jenny,Subramaniyan Boopathi,Hao Yangyang,Liu Yunlong,He Zhimin,Liu Jing-Yuan,Zhang Jian-Ting^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference30 articles.

1. Molecular predictors of gemcitabine response in pancreatic cancer, World;Voutsadakis;J. Gastrointest. Oncol.,2011

2. Reversible epigenetic regulation of 14-3-3sigma expression in acquired gemcitabine resistance by uhrf1 and DNA methyltransferase 1;Qin;Mol. Pharmacol.,2014

3. 14-3-3sigma Regulation of and Interaction with YAP1 in Acquired Gemcitabine Resistance via Promoting Ribonucleotide Reductase Expression;Qin;Oncotarget,2016

4. SOAP2: an improved ultrafast tool for short read alignment;Li;Bioinformatics,2009

5. The DNA methylome of human peripheral blood mononuclear cells;Li;PLoS Biol.,2010

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of a new scoring system for assessing nerve invasion in resected pancreatic cancer: A single-center retrospective analysis;Cancer Letters;2024-10

2. YBX1 as a therapeutic target to suppress the LRP1-β-catenin-RRM1 axis and overcome gemcitabine resistance in pancreatic cancer;Cancer Letters;2024-10

3. Addressing chemoresistance with a lipid gemcitabine nanotherapeutic strategy for effective treatment of pancreatic cancer;Nano Research;2024-08-01

4. SIRT7 knockdown promotes gemcitabine sensitivity of pancreatic cancer cell via upregulation of GLUT3 expression;Cancer Letters;2024-08

5. 6:2 Cl-PFESA, a proposed safe alternative for PFOS, diminishes the gemcitabine effectiveness in the treatment of pancreatic cancer;Journal of Hazardous Materials;2024-08